| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/30/1997 | CA2186716A1 Hydroxypyridinones |
| 03/30/1997 | CA2186561A1 Heterocyclic aryl-, alkyl and cycloalkylacetamides |
| 03/28/1997 | CA2186580A1 Substituted benzoylguanidines, a process for their preparation, their use as medicament or diagnostic agent, and medicament comprising them |
| 03/27/1997 | WO1997011192A1 Dna encoding medicinal proteins |
| 03/27/1997 | WO1997011178A1 Human growth hormone variants |
| 03/27/1997 | WO1997011071A1 Novel heterocyclic compounds |
| 03/27/1997 | WO1997011053A1 Calcitriol derivatives and their uses |
| 03/27/1997 | WO1997010847A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells |
| 03/27/1997 | WO1997010825A1 SELECTIVE β3 ADRENERGIC AGONISTS |
| 03/27/1997 | WO1997010822A1 SELECTIVE β3 ADRENERGIC AGONISTS |
| 03/27/1997 | WO1997010820A1 Stable vitamin c preparation |
| 03/27/1997 | WO1997010819A1 Treating niddm with rxr agonists |
| 03/27/1997 | WO1997010818A1 Method and composition for treating mammalian diseases caused by inflammatory response |
| 03/27/1997 | WO1997005253A3 Transketolase-related protein |
| 03/27/1997 | WO1997000088A3 Rotavirus enterotoxin nsp4 and methods of using same |
| 03/27/1997 | WO1996039156A3 Phosphate-binding polymers for oral administration |
| 03/27/1997 | CA2658039A1 Human growth hormone variants |
| 03/27/1997 | CA2232834A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells |
| 03/27/1997 | CA2232434A1 Selective .beta.3 adrenergic agonists |
| 03/27/1997 | CA2232193A1 Dna encoding medicinal proteins |
| 03/27/1997 | CA2232090A1 Selective .beta.3 adrenergic agonists |
| 03/27/1997 | CA2231835A1 Novel heterocyclic compounds |
| 03/26/1997 | EP0764722A2 DNA encoding primate leptins as medicinal proteins |
| 03/26/1997 | EP0764721A1 ATP-sensitive potassium-channel proteins and genes for the same |
| 03/26/1997 | EP0764640A1 Selective beta3 adrenergic agonists |
| 03/26/1997 | EP0764637A2 2-Cyano-3-mercaptocrotonamides |
| 03/26/1997 | EP0764632A2 Selective beta3 adrenergic agonists |
| 03/26/1997 | EP0764204A1 HUMAN OXALYL-CoA DECARBOXYLASE |
| 03/26/1997 | EP0764177A1 Cross-linked polymers for removing bile salts from a patient |
| 03/26/1997 | EP0764174A1 Process for removing bile salts from a patient and alkylated compositions therefor |
| 03/26/1997 | EP0764166A1 Corticotropin releasing factor antagonists |
| 03/26/1997 | EP0764026A1 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| 03/26/1997 | EP0649405B1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs |
| 03/26/1997 | EP0618917B1 1'-amino-2- (benzothiazolyl)methyl]spiro isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors |
| 03/26/1997 | EP0559751B1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
| 03/26/1997 | CN1145899A Substituted guanidine cinnamate, its prepn., its application as medicine or diagnosing agent and medicine containing the compound |
| 03/26/1997 | CN1145896A New alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them |
| 03/26/1997 | CN1145894A New arylalkyl (thio) carboxamides, processes for preparing them and pharmacetuical compositions containing them |
| 03/26/1997 | CN1145783A Pharmaceutical composition |
| 03/25/1997 | US5614551 Inhibitors of fatty acid synthesis as antimicrobial agents |
| 03/25/1997 | US5614550 Anticholesterol agents or arteriosclerosis agents for humans |
| 03/25/1997 | US5614542 Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use |
| 03/25/1997 | US5614541 Pharmacologically active catechol derivatives |
| 03/25/1997 | US5614534 Derivatives of β, β-dimethyl-4-piperidineethanamine as inhibitors of the cholesterol biosynthesis |
| 03/25/1997 | US5614531 Adhesion receptor antagonists |
| 03/25/1997 | US5614513 Release agent binder for vitamin d compounds and derivatives |
| 03/25/1997 | US5614508 Antiischemic agents, alzheimers, stroke or nervous system disorders |
| 03/25/1997 | US5614507 Protein and peptide free, neutral lipid and phospholipid containing compositions useful in treating endotoxemia |
| 03/25/1997 | US5614213 Use of estriol for treatment of climacteric osteoporosis |
| 03/20/1997 | WO1997010219A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases |
| 03/20/1997 | WO1997010212A1 Piperidine compounds as calcium channel blockers |
| 03/20/1997 | WO1997010006A1 Method for inhibiting cell-mediated killing of target cells |
| 03/20/1997 | WO1997009987A1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 03/20/1997 | WO1997009981A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 03/20/1997 | CA2231804A1 Method for inhibiting cell-mediated killing of target cells |
| 03/20/1997 | CA2185850A1 2-cyano-3-mercaptocrotonamides |
| 03/19/1997 | EP0763541A1 11-(Substituted phenyl)-estra-4,9-diene derivatives |
| 03/19/1997 | EP0763527A1 Substituted 2,2-dimethyl-omega-phenoxy alkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
| 03/19/1997 | EP0763116A1 Recombinant viruses, preparation and use thereof in gene therapy |
| 03/19/1997 | EP0763037A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763036A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763022A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and thiomorpholines as calcium channel antagonists |
| 03/19/1997 | EP0763021A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and tiomorpholines as calcium channel antagonists |
| 03/19/1997 | EP0762890A1 Treatment of diabetes |
| 03/19/1997 | EP0762886A1 Icam-1/lfa-1 short-chain peptides and method of using same |
| 03/19/1997 | EP0762883A1 Pyridylbisphosphonates for use as a therapeutical agent |
| 03/19/1997 | EP0762882A1 Vitronectin receptor antagonists |
| 03/19/1997 | EP0762877A1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof |
| 03/19/1997 | EP0725573A4 Ready-to-eat cereals containing extruded pre-wetted psyllium |
| 03/19/1997 | EP0429679B1 Potassium-supplementing preparation |
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
| 03/19/1997 | CN1145618A New piperidine derivatives |
| 03/19/1997 | CN1145360A Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
| 03/19/1997 | CA2182541A1 Novel, ubiquitous potassium-channel proteins and genes for the same |
| 03/19/1997 | CA2181880A1 Atp-sensitive potassium-channel proteins and their genes |
| 03/18/1997 | US5612359 Substituted biphenyl isoxazole sulfonamides |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/18/1997 | US5612335 Anticoagulants; combating/preventing diseases where cell aggregates occur or cell-matrix interactions play a part |
| 03/18/1997 | US5612325 Antiinflammatory and immunomodulating effects |
| 03/18/1997 | US5612312 (igf-i)insulin-like growth factor i |
| 03/18/1997 | CA2008341C Benzocycloalcenyl dihydroxy alcanoic acid derivatives, process for their preparation and drugs containing the same |
| 03/18/1997 | CA2000937C Preparation of riboflavin-5'-phosphate (5'-fmn) and its sodium salt, and of riboflavin-4',5'-cyclophosphoric acid ester chloride as an intermediate |
| 03/13/1997 | WO1997009060A1 Method of treating insulin resistance |
| 03/13/1997 | WO1997009057A1 Medicinal composition for diabetes |
| 03/13/1997 | WO1997009046A1 Compounds and methods |
| 03/13/1997 | WO1997009044A1 Pentacyclic compounds, intermediates, processes, compositions, and methods |
| 03/13/1997 | WO1997009040A1 2-alkylpyrrolidines |
| 03/13/1997 | WO1997008934A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/13/1997 | WO1997002826A3 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
| 03/13/1997 | WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 03/13/1997 | CA2230974A1 Pentacyclic compounds, intermediates, processes, compositions, and methods |
| 03/13/1997 | CA2230968A1 Method of treating insulin resistance |
| 03/13/1997 | CA2224874A1 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/12/1997 | EP0761669A2 Pentacyclic compounds, intermediates, processes, compositions, and methods |
| 03/12/1997 | EP0761659A1 Naphthyl and dihydronaphthyl compounds as medicaments |
| 03/12/1997 | EP0760819A1 Tricyclic dicarbonyl derivatives |
| 03/12/1997 | EP0760677A1 A pharmaceutical preparation comprising glucagon |
| 03/12/1997 | EP0760676A1 Materials and methods for treatment of plaquing diseases |
| 03/12/1997 | EP0760673A1 INHIBITION OF ATTACHMENT OF $i(H. INFLUENZAE) TO HUMAN CELLS |
| 03/12/1997 | EP0760670A1 Cellular factors that regulate the expression of genes encoding proteins involved in cholesterol homeostasis |